Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

OBIOOBIO
10 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in ORCHESTRA BIOMED HLDGS INC

Bank of New York Mellon Corp holds 86,103 shares of OBIO (ORCHESTRA BIOMED HLDGS INC), worth $371,534 as of 2026-Q2. This is a new position. OBIO represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$371,534

Current Shares

86,103

Total Value Change

+$280,912

Total Shares Change

+73,157

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
86,103
-
$371,5340.0%$4.32
33
2025-Q2
Exited
0
-100.0%
$00.0%$2.78
0
2025-Q1
Decreased
52,490
-0.6%
$224,6570.0%$4.40
0
2024-Q4
Increased
52,805
+0.6%
$211,2200.0%$4.25
16
2024-Q3
Decreased
52,490
-25.7%
$269,7990.0%$5.02
0
2024-Q2
Increased
70,682
+115.7%
$576,0590.0%$8.15
39
2024-Q1
Decreased
32,776
-30.6%
$172,7290.0%$5.27
0
2023-Q4
Increased
47,230
+17.2%
$431,2100.0%$9.13
28
2023-Q3
Increased
40,290
+211.2%
$351,3290.0%$8.72
38
2023-Q2
New
12,946
-
$90,6220.0%$7.57
33

Other major holders of OBIO: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used